Follow on Google News News By Tag * Glaxosmithkline * Prescription * Pharmaceutical * 2003-15 * 2003-09 * Pharmavitae * Vaccine * Configuration * Molecule * Therapy * More Tags... Industry News News By Location Country(s) Industry News
Follow on Google News | GlaxoSmithKline plc: PharmaVitae Profile: New research report available at Fast Market ResearchNew Healthcare research report from Datamonitor is now available from Fast Market Research
Reasons to Purchase * Benchmark GlaxoSmithKline's performance against key rivals in the prescription pharmaceutical sector * Assess the threat posed by generic competition to GlaxoSmithKline's core prescription pharmaceutical business * Analyze the future strategic direction of GSK, namely an enhanced vaccine offering, geographic diversification and increased biologics presence For more information or to purchase this report, go to: - http://www.fastmr.com/ Partial Table of Contents: ABOUT DATAMONITOR HEALTHCARE 2 About the PharmaVitae team 2 Chapter 1 About this profile 3 PharmaVitae Explorer database 3 Chapter structure 3 Executive summary 3 Quarterly update 3 Company introduction 3 Company sales 4 Company financials 4 Key products 4 Data sourcing 4 Sales data 4 Analyst consensus 4 Chapter 2 Executive summary 5 Key findings 5 Prescription pharmaceutical sales and growth rate performance, 2003-15 6 Financial performance, 2003-15 7 GlaxoSmithKline: Strategic insight 9 Introduction 9 Analysis of sales performance 2002-08 9 Analysis of sales performance 2009-15 11 Significantly improved launch outlook indicates that pipeline delivery continues to improve 11 Negative impact of generic exposure is stabilizing 12 Long term outlook improved by strategic re-direction implemented by new CEO 12 Outlook 12 SWOT analysis 14 Strengths 14 Weaknesses 15 Opportunities 16 Threats 17 Table of Contents 19 Table of figures 21 Chapter 3 Quarterly news update 22 Latest quarterly sales 22 Latest comment 23 Q2 2010 23 GlaxoSmithKline: Q1 2010 24 GlaxoSmithKline: Q4 2009 25 Genmab/GlaxoSmithKline: GlaxoSmithKline: Q3 2009 26 GlaxoSmithKline: Genmab/GlaxoSmithKline: Latest prescription pharma product news 28 Q2 2010 28 Q1 2010 29 Q4 2009 31 Q3 2009 32 Latest corporate news 34 Q2 2010 34 Q1 2010 34 Q4 2009 35 Q3 2009 36 Future product milestones 38 Chapter 4 Company introduction 40 Key findings 40 Background 41 M&A history 41 Glaxo and Wellcome 41 Glaxo Wellcome 41 Smith Kline and Beecham 41 SmithKline Beecham 42 Key historical drug launches by component GSK companies 43 M&A strategy 43 R&D overview 46 Chapter 5 Company sales 48 Key findings 48 Prescription pharmaceutical sales and growth rate analysis, 2003-15 49 Product analysis 51 Product analysis, 2003-09 52 Product analysis, 2009-15 55 Therapy area analysis 59 Geographic analysis 61 Launch/core/ Explanation of launch/core/ Launch analysis, 2009-15 64 Core analysis, 2009-15 66 Expiry analysis, 2009-15 68 Launch/core/ Molecule type analysis 70 Externalization analysis 74 Chapter 6 Company financials 77 Key findings 77 Reconciliation between PharmaVitae- Operating costs and profit analysis 79 Operating costs and profit analysis, 2003-09 80 Operating cost ratio and profit margin analysis, 2003-09 81 Operating cost ratio and profit margin analysis, 2009-15 82 Operating costs and profit analysis, 2009-15 83 Chapter 7 Key products 84 Overview 84 Beyond Advair 85 Summary 86 Sales forecast 87 Duodart 87 Summary 88 Sales forecast 89 Almorexant 89 Summary 90 Sales forecast 91 Tykerb/Tyverb 91 Summary 92 Sales forecast 93 Synflorix 93 Summary 94 Sales forecast 95 Valtrex 95 Summary 96 Sales forecast 97 Seretide/Advair 97 Summary 98 Sales forecast 99 Influenza Vaccines 99 Summary 100 Sales forecast 101 Flixotide/Flovent 101 Summary 102 Sales forecast 103 Avandia 103 Summary 105 Sales forecast 106 Chapter 8 Appendix 107 References 107 Abbreviations 107 Exchange rates 108 About Datamonitor 109 About Datamonitor Healthcare 109 Datamonitor consulting 109 Disclaimer 111 List of Tables Table 1: GlaxoSmithKline - PharmaVitae forecasts at a glance 8 Table 2: GlaxoSmithKline quarterly sales ($m), Q109-Q110 22 Table 3: GlaxoSmithKline future product milestones, 2010-12 38 Table 4: GlaxoSmithKline product portfolio overview ($m), 2003-09 52 Full Table of Contents is available at: -- http://www.fastmr.com/ About Datamonitor The Datamonitor Group is a world-leading provider of premium global business information, delivering independent data, analysis and opinion across the Automotive, Consumer Markets, Energy & Utilities, Financial Services, Logistics & Express, Pharmaceutical & Healthcare, Retail, Technology and Telecoms industries. Datamonitor's market intelligence products and services ensure that you will achieve your desired commercial goals by giving you the insight you need to best respond to your competitive environment. View more research from Datamonitor at http://www.fastmr.com/ About Fast Market Research Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156. # # # Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available. End
Account Email Address Account Phone Number Disclaimer Report Abuse
|